Ann: Investor Update, page-120

Mr/ Mrs Contrarian

It’s becoming clear your idea of reading announcements differs from mine, perhaps “what actually eventuates” is what’s stated you just haven’t studied available information.
If a director bends the truth it’s soon found out, only by reading everything multiple times it’s harder to miss important clues.
I’ve personally invested in PCK for the management first, product second. When I decided to invest 40% of the world market was already approved (TGA & CE)
The changed timeline for FDA approval was always possible due to unknown class of which painchek would be labelled, management had known this because USA was not in the commercial strategy until 2020 anyway.
The strategy was formulated and published well before they submitted for FDA clearance.

To make an informed investment decision you need to research all information before deciding if it’s “company spin” or you could just throw a dart ?.
The unknown for some is exciting I don’t have any problem with that.